comparemela.com

Latest Breaking News On - Kathyv turner - Page 2 : comparemela.com

Washington Trust Advisors Inc Has $38,000 Position in IDEXX Laboratories, Inc (NASDAQ:IDXX)

Washington Trust Advisors Inc. lessened its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 69.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92 shares of the company’s stock after selling 209 shares during the quarter. Washington Trust Advisors Inc.’s holdings […]

IDEXX Laboratories, Inc (NASDAQ:IDXX) Position Trimmed by Biondo Investment Advisors LLC

Biondo Investment Advisors LLC cut its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 5.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,893 shares of the company’s stock after selling 2,431 shares during the quarter. IDEXX Laboratories makes up […]

Dakota Wealth Management Has $699,000 Stake in IDEXX Laboratories, Inc (NASDAQ:IDXX)

Dakota Wealth Management boosted its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 4.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,713 shares of the company’s stock after buying an additional 68 shares during the period. Dakota […]

IDEXX Laboratories, Inc (NASDAQ:IDXX) Shares Sold by Arizona State Retirement System

Arizona State Retirement System lowered its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 0.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,685 shares of the company’s stock after selling 150 shares during the quarter. Arizona State Retirement […]

IDEXX Laboratories (NASDAQ:IDXX) Issues FY23 Earnings Guidance

IDEXX Laboratories (NASDAQ:IDXX – Get Rating) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided EPS guidance of $9.33-$9.75 for the period, compared to the consensus EPS estimate of $9.63. The company issued revenue guidance of $3.619-$3.70 billion, compared to the consensus revenue estimate of $3.66 billion. Analyst Ratings Changes […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.